USEUROPEAFRICAASIA 中文雙語Fran?ais
    China
    Home / China / Innovation

    Chinese scientists supercharge virus to kill cancer cells

    China Daily | Updated: 2017-08-25 08:45

    Chinese scientists have found a compound that appears to enhance the ability of a virus to target and kill liver cancer cells while sparing healthy cells. The discovery offers new hope for treating the world's second-most common form of cancer, according to a study published on Wednesday.

    A therapy using viruses that selectively kill cancer cells-called oncolytic viruses-is rapidly progressing through clinical evaluation, but the therapeutic efficacy in humans has been less than expected in preclinical studies, the study said. It was published in the US journal Science Translational Medicine.

    Oncolytic virotherapy involving the M1 virus, a mosquito-borne pathogen that mainly causes mild illnesses in horses, is believed to have potential for the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.

    In order to boost the virus's antitumor effects, Yan Guangmei, a professor at Sun Yat-sen University, together with colleagues, screened 350 small molecules to identify compounds that can enhance viral killing of cultured HCC cells.

    The researchers found that Eeyarestatin I-an inhibitor of the protein VCP, which may help trigger cell malignancy-increased the potency of the M1 virus by as much as 3,600-fold against the HCC cells.

    The dual regimen had no effect on noncancerous cells, they said.

    In multiple mouse models of HCC, a combination of M1 and Eeyarestatin I was found to shrink tumors and significantly prolong survival.

    Researchers further demonstrated that the combination was safe and well-tolerated in monkeys.

    "We can describe the M1 oncolytic virus as a guided missile that automatically targets tumor cells, and the addition of the VCP inhibitor is just like binding the missile to powerful explosives with the ability for auto-selection," Yan said.

    "The outcome is evident with such a strong combination," he said.

    Yan said the team plans to submit a clinical trial application for the combination therapy strategy in 2018.

    Xinhua

    Editor's picks
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    免费a级毛片无码免费视频| 中文字幕无码日韩专区免费| 无码AV中文一区二区三区| 无码日韩精品一区二区三区免费| а天堂中文在线官网| 精品无码久久久久久久久久| 亚洲欧洲日产国码无码久久99| 人妻中文字幕无码专区| 国产真人无码作爱免费视频| 无码国产精品一区二区免费模式 | 最近中文字幕mv免费高清视频8| 18禁免费无码无遮挡不卡网站| 中文人妻无码一区二区三区 | 亚洲中文字幕无码永久在线| 国产在线拍揄自揄拍无码| 最新中文字幕AV无码不卡| 日韩乱码人妻无码中文字幕视频 | 日韩中文字幕电影| 亚洲精品国产日韩无码AV永久免费网| 亚洲AV永久无码精品成人| 国产成人无码一二三区视频| 最近2022中文字幕免费视频| 久久超乳爆乳中文字幕 | 中文字幕亚洲色图| 精品久久亚洲中文无码| 无码精品人妻一区二区三区影院| 免费A级毛片av无码| 无码人妻AV一二区二区三区| 亚洲精品无码专区久久久| 国产成人无码一二三区视频| 最近2019中文字幕大全第二页| 精品久久久久久无码中文野结衣| 亚洲欧美日韩国产中文| 亚洲欧美日韩中文字幕一区二区 | 久久精品中文字幕第23页| 日本一区二区三区精品中文字幕 | 国产网红主播无码精品| 高清无码v视频日本www| 亚洲热妇无码AV在线播放| 亚洲AV无码国产精品色午友在线| 人妻无码αv中文字幕久久|